Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Multiscale BerEp4 molecular imaging of microtumor phantoms: toward theranostics for basal cell carcinoma.

Dasgeb B, Smirnov AV, Ardeshirpour Y, Sackett DL, Knutson JR, Mehregan D, Gandjbakhche A, Halpern AC.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00016.

2.

The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.

Sellheyer K, Nelson P, Kutzner H, Patel RM.

J Cutan Pathol. 2013 Apr;40(4):363-70. doi: 10.1111/cup.12085. Epub 2013 Feb 11.

PMID:
23398472
3.

Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.

Yu L, Galan A, McNiff JM.

J Cutan Pathol. 2009 Oct;36(10):1074-176. doi: 10.1111/j.1600-0560.2008.01223.x. Epub 2009 Jan 27.

PMID:
19187107
4.

Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression.

Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM.

Am J Surg Pathol. 2014 Apr;38(4):542-7. doi: 10.1097/PAS.0000000000000143.

PMID:
24625418
5.

Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.

Karen JK, Gareau DS, Dusza SW, Tudisco M, Rajadhyaksha M, Nehal KS.

Br J Dermatol. 2009 Jun;160(6):1242-50. doi: 10.1111/j.1365-2133.2009.09141.x. Epub 2009 Mar 30.

6.

Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma.

Dasgeb B, Mohammadi TM, Mehregan DR.

Biomark Cancer. 2013 Jun 25;5:7-11. doi: 10.4137/BIC.S11856. eCollection 2013.

7.

Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma.

Goldgeier M, Fox CA, Zavislan JM, Harris D, Gonzalez S.

Dermatol Surg. 2003 Mar;29(3):205-10.

PMID:
12614409
8.

Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study.

Nori S, Rius-Díaz F, Cuevas J, Goldgeier M, Jaen P, Torres A, González S.

J Am Acad Dermatol. 2004 Dec;51(6):923-30.

PMID:
15583584
9.

Laser-induced fluorescence made simple: implications for the diagnosis and follow-up monitoring of basal cell carcinoma.

Drakaki E, Dessinioti C, Stratigos AJ, Salavastru C, Antoniou C.

J Biomed Opt. 2014 Mar;19(3):30901. doi: 10.1117/1.JBO.19.3.030901.

PMID:
24604472
10.

Diagnosis of BCC by multiphoton laser tomography.

Seidenari S, Arginelli F, Bassoli S, Cautela J, Cesinaro AM, Guanti M, Guardoli D, Magnoni C, Manfredini M, Ponti G, König K.

Skin Res Technol. 2013 Feb;19(1):e297-304. doi: 10.1111/j.1600-0846.2012.00643.x. Epub 2012 Jul 8.

PMID:
22776020
11.

BerEP4-negative basal cell carcinoma on the palm: case report and review of the literature.

Mleczko A, Franke I, Pokrywka A, Gollnick H, Leverkus M.

J Dtsch Dermatol Ges. 2011 Feb;9(2):140-3. doi: 10.1111/j.1610-0387.2010.07475.x. Review. English, German.

PMID:
20629842
12.

Imaging of basal cell carcinoma by high-definition optical coherence tomography: histomorphological correlation. A pilot study.

Boone MA, Norrenberg S, Jemec GB, Del Marmol V.

Br J Dermatol. 2012 Oct;167(4):856-64. doi: 10.1111/j.1365-2133.2012.11194.x.

PMID:
22862425
13.

In vivo diagnosis of basal cell carcinoma subtype by reflectance confocal microscopy.

Peppelman M, Wolberink EA, Blokx WA, van de Kerkhof PC, van Erp PE, Gerritsen MJ.

Dermatology. 2013;227(3):255-62. doi: 10.1159/000354762. Epub 2013 Oct 18.

PMID:
24158236
14.

Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics.

Seidenari S, Arginelli F, Dunsby C, French P, König K, Magnoni C, Manfredini M, Talbot C, Ponti G.

Exp Dermatol. 2012 Nov;21(11):831-6. doi: 10.1111/j.1600-0625.2012.01554.x. Epub 2012 Aug 7.

PMID:
22882324
15.

Detection of residual basal cell carcinoma by in vivo confocal microscopy.

Marra DE, Torres A, Schanbacher CF, Gonzalez S.

Dermatol Surg. 2005 May;31(5):538-41.

PMID:
15962737
16.

BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error.

Afshar M, Deroide F, Robson A.

J Cutan Pathol. 2013 Feb;40(2):259-64. doi: 10.1111/cup.12043. Epub 2012 Nov 29.

PMID:
23194306
17.

Direct observation of spectral differences between normal and basal cell carcinoma (BCC) tissues using confocal Raman microscopy.

Choi J, Choo J, Chung H, Gweon DG, Park J, Kim HJ, Park S, Oh CH.

Biopolymers. 2005 Apr 5;77(5):264-72.

PMID:
15657894
18.

High-contrast mapping of basal cell carcinomas.

Yaroslavsky AN, Patel R, Salomatina E, Li C, Lin C, Al-Arashi M, Neel V.

Opt Lett. 2012 Feb 15;37(4):644-6. doi: 10.1364/OL.37.000644.

PMID:
22344134
19.

Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regression.

Maier T, Kulichova D, Ruzicka T, Berking C.

J Am Acad Dermatol. 2014 Oct;71(4):725-30. doi: 10.1016/j.jaad.2014.04.007. Epub 2014 Jun 11.

PMID:
24928708
20.

Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.

Venturini M, Sala R, Gonzàlez S, Calzavara-Pinton PG.

Br J Dermatol. 2013 Jan;168(1):99-105. doi: 10.1111/bjd.12052.

PMID:
23013443
Items per page

Supplemental Content

Write to the Help Desk